Free Trial

SNDL (SNDL) Competitors

SNDL logo
$1.27 +0.03 (+2.00%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$1.27 0.00 (-0.39%)
As of 07/3/2025 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNDL vs. ACB, CGC, CRON, OGI, TLRY, CVAC, CALT, GPCR, AUPH, and NAGE

Should you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), Tilray Brands (TLRY), CureVac (CVAC), Calliditas Therapeutics AB (publ) (CALT), Structure Therapeutics (GPCR), Aurinia Pharmaceuticals (AUPH), and Niagen Bioscience (NAGE). These companies are all part of the "medical" sector.

SNDL vs. Its Competitors

SNDL (NASDAQ:SNDL) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.

SNDL has a beta of 3.4, meaning that its stock price is 240% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.75, meaning that its stock price is 75% more volatile than the S&P 500.

Aurora Cannabis has lower revenue, but higher earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SNDL$671.81M0.50-$69.18M-$0.29-4.40
Aurora Cannabis$246.72M1.04$1.63M$0.1141.59

47.6% of Aurora Cannabis shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Aurora Cannabis had 3 more articles in the media than SNDL. MarketBeat recorded 4 mentions for Aurora Cannabis and 1 mentions for SNDL. SNDL's average media sentiment score of 0.59 beat Aurora Cannabis' score of -0.17 indicating that SNDL is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SNDL
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

SNDL presently has a consensus target price of $3.63, suggesting a potential upside of 184.31%. Given SNDL's higher possible upside, research analysts clearly believe SNDL is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67

Aurora Cannabis has a net margin of 1.32% compared to SNDL's net margin of -11.48%. Aurora Cannabis' return on equity of 0.13% beat SNDL's return on equity.

Company Net Margins Return on Equity Return on Assets
SNDL-11.48% -9.02% -7.60%
Aurora Cannabis 1.32%0.13%0.10%

Summary

Aurora Cannabis beats SNDL on 12 of the 16 factors compared between the two stocks.

Get SNDL News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNDL vs. The Competition

MetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$335.04M$10.19B$5.49B$9.02B
Dividend YieldN/A2.09%5.38%4.09%
P/E Ratio-4.4016.7427.4720.28
Price / Sales0.5029.14408.30121.41
Price / CashN/A22.8436.6357.47
Price / Book0.403.668.095.67
Net Income-$69.18M$235.40M$3.17B$248.96M
7 Day Performance3.66%2.15%2.82%3.30%
1 Month Performance-1.16%3.00%3.69%5.20%
1 Year Performance-34.95%-10.21%35.42%21.37%

SNDL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNDL
SNDL
3.3383 of 5 stars
$1.28
+2.0%
$3.63
+184.3%
-34.9%$335.04M$671.81M-4.402,516News Coverage
ACB
Aurora Cannabis
0.2115 of 5 stars
$4.24
+2.2%
N/A-6.6%$238.33M$246.72M38.551,130
CGC
Canopy Growth
2.8352 of 5 stars
$1.22
flat
$2.00
+63.9%
-80.0%$224.32M$225.65M-0.303,150
CRON
Cronos Group
2.3339 of 5 stars
$1.91
+0.5%
N/A-12.1%$736.65M$117.61M14.69450News Coverage
OGI
Organigram Global
0.6811 of 5 stars
$1.35
flat
N/A-10.7%$180.82M$117.47M13.50860
TLRY
Tilray Brands
1.7866 of 5 stars
$0.41
+3.4%
$1.92
+362.5%
-69.3%$417.09M$210.48M-0.392,650Options Volume
CVAC
CureVac
4.6485 of 5 stars
$5.43
+0.9%
$6.83
+25.8%
+72.9%$1.22B$579.18M5.90880
CALT
Calliditas Therapeutics AB (publ)
N/A$40.00
flat
N/AN/A$1.19B$1.60B-21.62180
GPCR
Structure Therapeutics
2.969 of 5 stars
$20.74
-1.6%
$76.17
+267.2%
-44.9%$1.19BN/A-23.84136Positive News
AUPH
Aurinia Pharmaceuticals
3.2766 of 5 stars
$8.47
-2.0%
$11.50
+35.8%
+38.3%$1.14B$235.13M30.25300
NAGE
Niagen Bioscience
1.527 of 5 stars
$14.41
+1.3%
$19.50
+35.3%
N/A$1.14B$107.93M84.76120

Related Companies and Tools


This page (NASDAQ:SNDL) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners